Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

International Journal of Cancer

Volumn 67, Issue 1, 1996, Pages 54-62

  Jäger, Elke ^a   Ringhoffer, Mark ^a   Dienes, Hans Peter ^b   Arand, Michael ^b   Karbach, Julia ^a   Jäger, Dirk ^a   Ilsemann, Christiane ^c   Hagedorn, Manfred ^c   Oesch, Franz ^b   Knuth, Alexander ^a  

^a KRANKENHAUS NORDWEST   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c KLINIKUM DARMSTADT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA A2 ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELANOMA ANTIGEN; MELANOMA VACCINE; MONOPHENOL MONOOXYGENASE; SYNTHETIC PEPTIDE;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DOSE RESPONSE; ERYTHEMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INJECTION PAIN; INTRADERMAL DRUG ADMINISTRATION; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; PRURITUS; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR REGRESSION; TUMOR REJECTION; VITILIGO;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0041485051     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960703)67:1<54::AID-IJC11>3.0.CO;2-C     Document Type: Article

References (28)

1. ALIJAGICS., MÜLLER, P., ARTUC, M., JURGOVSKY, K., CZARNETZKI, B.M. and SCHADENDORF, D., Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T-cell activation. Europ. J. Immunol., 25, 3100-3107 (1995).
2. BARKERA.B., SCHREURS, M.W.J., DEBOER, A.J., KAWAKAMI, Y., ROSENBERG, S.A., ADEMA, G.J. and FIGDOR, C.G., Melanocyte-lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. exp. Med., 179, 1005-1009 (1994).
3. + cytolytic T-cell responses. J. exp. Med., 182, 1663-1671 (1995).
4. BOOMERH., OGG, G., GOTCH, F. and MCMICHAEL, A., Anti-HLA-A2-antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes. Nature (Lond.), 342, 443-446 (1989).
5. BRICHARDV., VAN PEL, A., WÖLFEL, T., WÖLFEL, C., DEPLAEN, E., LETHE, B., COULIE, P. and BOON, T., The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 178, 489-495 (1993).
6. CAUXC., DEZUTTER-DAMBUYANT, C. and SCHMITT, D., GM-CSF and TNFa cooperate in the generation of dendritic Langerhans cells. Nature (Lond.), 360, 258-261 (1992).
7. COULIEP.G., BRICHARD, V., VAN PEL, A., WÖLFEL, T., SCHNEIDER, J., TRAVERSARI, C., MATTEI, S., DEPLAEN, E., LURQUIN, C., SZIKORA, J.-P., RENAULD, J.-C. and BOON, T., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 180, 35-42 (1994).
8. COULIEP.G., LEHMANN, F., LETHE, B., HERMAN, J., LURQUIN, C., ANDRAWISS, M. and BOON, T., A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. nat. Acad. Sci. (Wash.), 92, 7976-7980 (1995).
9. DRANOFFG., JAFFEE, E., LAZENBRY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JECKSON, V., HAMADA, H., PARDOLL, D. and MULLIGAN, R., Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage-colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. nat. Acad. Sci. (Wash.), 90, 3539-3543 (1993).
10. JÄGERE., BERNHARD, H., ROMERO, P., RINGHOFFER, M., ARAND, M., KARBACH, J., ILSEMANN, C., HAGEDORN, M. and KNUTH, A., Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int. J. Cancer, 66, 162-169 (1996a).
11. JÄGERE., RlNGHOFFER, M., KARBACH, J., ARAND, M., OESCH, F. and KNUTH, A., Inverse relationship of melanocyte-differention-antigen expression in melanoma: evidence for immunoselection of antigen-loss variants in vivo. Int. J. Cancer, 66, 470-476 (1996b).
12. KANGX.Q., KAWAKAMI, Y., EL-GAMIL, M., WANG, R., SAKAGUCHI, K., YANNELLI, J.R., APPELLA, E. and ROSENBERG, S.A., Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J. Immunol., 155, 1343-1348 (1995).
13. KAWAKAMIY., ELIYAHU, S., DELGADO, C.H., ROBBINS, P.F., RIVOLTINI, L., TOPALIAN, S.L., MIKI, T. and ROSENBERG, S.A., Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. nat. Acad. Sci. (Wash.), 91, 3525-3519 (1994a).
14. KAWAKAMIY., ELIYAHU, S., DELGADO, C.H., ROBBINS, P.F., SAKAGUCHI, K., APPELLA, E., YANNELLI, J.R., ADEMA, G.J., MIKI, T. and ROSENBERG, S.A., Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. nat. Acad. Sci. (Wash.), 91, 6458-6462 (1994b).
15. KAWAKAMIY., ELIYAHU, S., JENNINGS, C., SAKAGUCHI, K., KANG, X.Q., SOUTHWOOD, S., ROBBINS, P.F., SETTE, A., APPELLA, E. and ROSENBERG, S.A., Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating lymphocytes associated with n vivo tumor regression. J. Immunol., 154, 3961-3968 (1995).
16. KNUTHA., WÖLFEL, T. and MEYER ZUM BÜSCHENFELDE, K.-H., T-cell responses to human malignant tumours. Cancer Surveys, 13, 39-52 (1992).
17. KOVACSOVICS-BANKOWSKIM. and ROCKK.L., A phagosome-to-cytosol pathway for exogenous antigens presented on MHC-class-I molecules. Science. 267, 243-246 (1995).
18. MANDELBOIMO., BERKE, G., FRIDKIN, M., FELDMAN, M., EISENSTEIN, M. and EISENBACH, L., CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature (Lond.), 369, 67-71 (1994).
19. MARCHAND, M. and 20 OTHERS, Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer, 63, 883-885 (1995).
20. MATZINGERP., Tolerance, danger, and the extended family. Ann. Rev. Immunol., 12, 991-1045 (1994).
21. NOGUCHIY., RICHARDS, E.G., CHEN, Y.T. and OLD, L.J., Influence of interleukin-12 on p53-peptide vaccination against established Meth A sarcoma. Proc. nat. Acad. Sci. (Wash.), 92, 2219-2223 (1995).
22. NORBURYC.C., HEWLETT, L.J., PRESCOTT, A.R., SHASTRI, N. and WATTS, C., Class-I-MHC presentation of exogenous soluble antigen via macropinocytosis in bone-marrow macrophages. Immunity, 3, 783-791 (1995).
23. ROBBINSP.F., EL-GAMIL, M., KAWAKAMI, Y. and ROSENBERG, S.A., Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res., 54, 3124-3126 (1994).
24. SCHIRMBECKR., MELBER, K. and REIMANN, J., Hepatitis-B-virus small-surface antigen particles are processed in a novel endosomal pathway for major-histocompatibility-complex-class-I-restricted epitope presentation. Europ. J. Immunol., 25, 1063-1070 (1995).
25. STERNBERGERL., Immunocytochemistry, 2nd ed., pp. 104-168, John Wiley, New York, Chichester, Brisbane, Toronto (1979).
26. VAN DER BRUGGENP., TRAVERSARI, C., CHOMEZ, P., LURQUIN, C., DE PLAEN, E., VAN DEN EYNDE, B., KNUTH, A. and BOON, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643-1647 (1991).
27. WÖLFELT., HAUER, M., SCHNEIDER, J., SERRANO, M., WÖLFEL, C., KLEHMANN-HIEB, E., DEPLAEN, E., HANKELN, T., MEYER ZUM BÜSCHENFELDE, K.-H. and BEACH, D., A p161NK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science, 269, 1281-1284 (1995).
28. WÖLFELT., SCHNEIDER, J., MEYER ZUM BÜSCHENFELDE, K.-H., RAMMENSEE, H.-G., RÖTZSCHKE, O. and FALK, K., Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1. Int. J. Cancer, 57, 413-418 (1994).